Clinical Trial Update: Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical tazarotene vs placebo for hand-foot skin reactions in solid tumor patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Skin Reaction
• Solid Tumor

Drugs mentioned

• TAZAROTENE (TAZAROTENE)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Solid Tumor, Hand-Foot Skin Reaction (HFSR) | Phase 2 | Status: TERMINATED | Results posted: 2023-11-15